Price movement over the last 24 hours
ALLORA vs Enzyme — how do they compare? ALLORA trades at Rp7,377 (market cap Rp1,48T, Rp705,57M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: ALLORA is far larger — about 11034.1× Enzyme's market cap, and ALLORA's supply is capped (200,5M / 1B ALLO (21%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold ALLORA for 2 Days and Enzyme for 28 Days on average.
| ALLO | MLN | |
|---|---|---|
Market Cap | Rp1,48T | Rp134,13M |
Volume (24h) | Rp705,57M | Rp104,56M |
Circulating Supply | 200,5M / 1B ALLO (21%) | 3,3M MLN |
Typical Hold Time | 2 Days | 28 Days |
Signals from Pluang's Aura AI — not financial advice
ALLO is currently trading at Rp7,376.18 with a market cap of Rp1.46T, showing bullish technical signals with strong moving average support. The token trades near its pivot point of Rp7,371 with immediate resistance at Rp7,657. While RSI_6 indicates overbought conditions at 78.46, overall market structure remains positive. The project maintains a fixed max supply of 1M tokens with 21% in circulation and relatively short average hold time of 2 days, suggesting active trading.
Outlook remains cautiously optimistic with technical strength but faces overbought risks. Key opportunities include potential breakout above Rp7,657 resistance, while major risks involve RSI overbought conditions and typical crypto volatility. Investors should monitor support at Rp6,865 for potential pullbacks.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
What Pluang investors did over the last 30 days
No sentiment data available yet.
APRO is a data-oracle protocol that brings real-world data to blockchain networks. It supports applications across RWA, AI, prediction markets, and DeFi by supplying reliable, on-chain data feeds. Its infrastructure leverages machine learning models to enhance data validation and sourcing, ensuring developers can access accurate, tamper-resistant information.
Read more on ALLO →Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →